Zoetis Inc.
Zoetis Inc. (ZTS) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · ZTS · as of Sep 30, 2024
Ownership Breakdown
1,834
Institutional Holders
▲ 42 vs Q2
$81.68B
Total Inst. Value
▲ $8.19B vs Q2
419.23M
Shares Outstanding
freeFloat 99.80%
419.56M
13F Shares Held
▼ 4.49M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
ZTS largest shareholders · institutional ownership
Q3 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC pharmaceutical preparations | 41.25M | 9.11% | 9.11% | $8.06T | Nov 13, 2024 | ▲ 31.2K |
BLACKROCK, INC. pharmaceutical preparations | 38.23M | 8.44% | 8.44% | $7.47T | Nov 13, 2024 | NEW |
STATE STREET CORP pharmaceutical preparations | 19.78M | 4.37% | 4.37% | $3.86T | Nov 14, 2024 | ▲ 95.9K |
STATE FARM MUTUAL AUTOMOBILE INSURANCE CO pharmaceutical preparations | 16.04M | 3.54% | 3.54% | $3.13T | Nov 12, 2024 | ▼ 113.8K |
ALLIANCEBERNSTEIN L.P. pharmaceutical preparations | 15.39M | 3.40% | 3.40% | $3.01T | Nov 14, 2024 | ▲ 414.2K |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 14.36M | 3.17% | 3.17% | $2.81T | Nov 14, 2024 | ▼ 732.6K |
MORGAN STANLEY pharmaceutical preparations | 12.04M | 2.66% | 2.66% | $2.35T | May 14, 2025 | ▼ 1.33M |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 10.43M | 2.30% | 2.30% | $2.03T | Nov 12, 2024 | ▲ 185.4K |
CAPITAL WORLD INVESTORS pharmaceutical preparations | 6.68M | 1.48% | 1.48% | $1.31T | Nov 13, 2024 | ▼ 99.4K |
POLEN CAPITAL MANAGEMENT LLC pharmaceutical preparations | 6.37M | 1.41% | 1.41% | $1.24T | Feb 10, 2025 | ▼ 679.4K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2024 vs prior quarter
Q3 2024
26
Increased
+5.07M shares1
New Positions
first time holders22
Decreased
−11.64M shares0
Sold Out
fully exitedNet shares change (top 50)
6.57M
+5.07M / −11.64M
Net new holders
+5
1 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
ZTS insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
14
Buy transactions
4
Sell transactions
3.50
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
DAMELIO FRANK A director | May 13, 2026 | Purchase | 6,650 | $75.39 | $501.3K | 21.5K | Form 4 ↗ |
Bisaro Paul director | May 13, 2026 | Purchase | 2,000 | $75.88 | $151.8K | 27.9K | Form 4 ↗ |
MCCALLISTER MICHAEL B director | May 11, 2026 | Purchase | 3,000 | $77.76 | $233.3K | 24.5K | Form 4 ↗ |
Esch Kevin Executive Vice President | Apr 30, 2026 | Tax Withhold | 75 | $114.97 | $8.6K | 578 | Form 4 ↗ |
FULLER JULIE Executive Vice President | Apr 10, 2026 | Award | 550.644 | — | — | 1.8K | Form 4 ↗ |
Lagano Roxanne Executive Vice President | Apr 10, 2026 | Award | 550.644 | — | — | 30.6K | Form 4 ↗ |
Ferran Astorga Jeannette Executive Vice President | Apr 10, 2026 | Award | 4.997 | — | — | 2.3K | Form 4 ↗ |
Esch Kevin Executive Vice President | Apr 10, 2026 | Award | 1.395 | — | — | 498.386 | Form 4 ↗ |
PECK KRISTIN C Chief Executive Officer | Apr 10, 2026 | Award | 2,776.77 | — | — | 65.6K | Form 4 ↗ |
Driscoll Rimma Executive Vice President | Apr 10, 2026 | Award | 26.198 | — | — | 6.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Zoetis Inc. (ZTS) is primarily owned by institutional investors, who hold approximately 100.0% of total shares outstanding. Company insiders own approximately 0.20%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Zoetis Inc. is VANGUARD GROUP INC, holding approximately 41.25 million shares — equal to 9.11% of outstanding shares — as of September 30, 2024.
A total of 1,834 institutional investors currently hold ZTS stock, with a combined institutional value of approximately $81.68 billion as of the most recent 13F filing period.
Frequently asked questions
ZTS ownershipZoetis Inc. (ZTS) is primarily owned by institutional investors, who hold approximately 100.0% of shares. The largest shareholder is VANGUARD GROUP INC with a 9.11% stake. Company insiders hold 0.20%. Data sourced from SEC Form 13F as of September 30, 2024.